Zimbabwe: US to cut health aid on September 30 following data refusal

The United States will end all of its health funding for Zimbabwe on September 30, 2026, following Harare's refusal to sign a new bilateral memorandum, according to allAfrica and the American press. For nearly twenty years, Washington has been the leading donor to the Zimbabwean health sector: providing antiretrovirals, testing, laboratories, and stipends for community health workers.

The sticking point is neither the amount nor the duration, but a data-sharing clause. Zimbabwean government spokesperson Nick Mangwana, quoted by the American press, asserts that the proposed text demanded "full access" to the country's sensitive health data, including virus samples and epidemiological information concerning its citizens.

The rejected agreement represented $367 million intended for the fight against HIV/AIDS, tuberculosis, and malaria, as well as maternal and child health and epidemic preparedness. It was part of a new American model requiring "co-investment" from beneficiary countries.

Twenty years of progress hanging on a signature

The U.S. Ambassador to Harare, Pamela Tremont, recalled that Zimbabwe has achieved control of the HIV epidemic, with more than 95% of HIV-positive individuals on treatment, and stated that the priority is now to preserve these gains "under Zimbabwean leadership." On the side of advocacy groups, the tone is harsher: Asia Russell, from the organization Health GAP, warned that this decision would trigger a "public health catastrophe," citing the shortages already experienced in 2025 regarding malaria, tuberculosis, and HIV.

A question of sovereignty that goes beyond Harare

Zimbabwe is not alone. Namibia has also refused an agreement of this type for reasons of data protection, and Ghana, Zambia, and South Africa have not concluded one, according to the American press. Conversely, about thirty countries have signed, the majority of which are on the continent. The dividing line is clear: who keeps control over health data, viral sequences, and samples collected from African populations, and at what price?

The Zimbabwean government says it wants to mobilize internal resources, a promise that public health actors deem difficult to keep for a state with fragile finances. These same actors are calling for the resumption of negotiations between Harare and Washington before the September 30, 2026 deadline. For the millions of patients involved, the trade-off between data sovereignty and the continuity of treatment cannot remain a diplomatic abstraction.